HIV Returns in Patients Thought Cured

The virus is back in two patients in Boston who received bone-marrow transplants and did not have detectable levels of virus for months.

Written byAbby Olena, PhD
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

HIV retrovirusWIKIMEDIA, PHD DRE

Physician-scientists reported in July that two male patients had stopped anti-retroviral therapy and were HIV-free after bone-marrow transplants that occurred in 2008 in one man and 2010 in the second. Now, the scientists have announced that HIV is back in both patients.

“It’s disappointing and very sobering,” virologist Deborah Persaud of the Johns Hopkins Children’s Center in Baltimore, Maryland, told Nature News.

The men were given high-risk bone-marrow transplants to treat blood cancer and had no detectable levels of HIV in their blood eight months post-transplant. They each stopped taking anti-retroviral drugs earlier this year and did not test positive for HIV for months. Timothy Henrich of Brigham and Women’s Hospital in Boston, one of the patients’ physicians, said today in a statement that one ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery